0001415889-23-016253.txt : 20231211
0001415889-23-016253.hdr.sgml : 20231211
20231211180025
ACCESSION NUMBER: 0001415889-23-016253
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231207
FILED AS OF DATE: 20231211
DATE AS OF CHANGE: 20231211
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GLENN JOHN
CENTRAL INDEX KEY: 0001253497
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36534
FILM NUMBER: 231479515
MAIL ADDRESS:
STREET 1: 7900 HOPYARD ROAD
STREET 2: APT 210
CITY: PLEASANTON
STATE: CA
ZIP: 94577
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IRADIMED CORP
CENTRAL INDEX KEY: 0001325618
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 731408526
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1025 WILLA SPRINGS DR.
CITY: WINTER SPRINGS
STATE: FL
ZIP: 32708
BUSINESS PHONE: 4076778022
MAIL ADDRESS:
STREET 1: 1025 WILLA SPRINGS DR.
CITY: WINTER SPRINGS
STATE: FL
ZIP: 32708
4
1
form4-12112023_061212.xml
X0508
4
2023-12-07
0001325618
IRADIMED CORP
IRMD
0001253497
GLENN JOHN
C/O IRADIMED CORPORATION
1025 WILLA SPRINGS DR.
WINTER SPRINGS
FL
32708
false
true
false
false
CHIEF FINANCIAL OFFICER
0
Restricted Stock Units
2023-12-07
4
A
0
7180
0
A
Common Stock
7180
35072
D
Performance-based Restricted Stock Units
2023-12-07
4
A
0
7180
0
A
Common Stock
7180
17684
D
Restricted stock units convert into common stock on a one-for-one basis.
The reporting person received restricted stock units ("RSUs") under Iradimed Corporation's 2014 Equity Incentive Plan. The RSUs vest in full on the third anniversary of the grant date, December 7, 2026. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.
The reporting person received performance-based restricted stock units ("PRSUs") under Iradimed Corporation's 2014 Equity Incentive Plan. Vesting of these PRSUs depends on the reporting person's achievement of specified relative ranking of total shareholder return over a three-year period from December 8, 2023 through December 7, 2026.
If the relative measure at December 7, 2026 and for the three-year period then ended is: (i) less than or equal to 80% of the peer group, no vesting would occur, (ii) between 80% and 100% of the peer group, the number of shares vesting would be pro-rata against the nominal granted shares, (iii) equal to 100% of the peer group, the number of shares vesting would be the nominal granted shares, (iv) between 100%and 120% of the peer group, the number of shares vesting would be pro-rata against an additional tranche of the nominal granted shares plus the nominal granted shares, and (v) if 120% or greater of the peer group, the number of shares vesting would be double the nominal granted shares.
Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of PRSUs that have vested.
/s/ John Glenn
2023-12-11